المؤلفون: Tesileanu, C Mircea S, van den Bent, Martin J, Sanson, Marc, Wick, Wolfgang, Brandes, Alba A, Clement, Paul M, Erridge, Sara C, Vogelbaum, Michael A, Nowak, Anna K, Baurain, Jean F, Mason, Warren P, Wheeler, Helen, Chinot, Olivier L, Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter, Ruda', Roberta, Weller, Michael, McBain, Catherine, van Linde, Myra E, Sabedot, Thais S, Hoogstrate, Youri, von Deimling, Andreas, de Heer, Iris, van IJcken, Wilfred F J, Brouwer, Rutger W W, Aldape, Kenneth, Jenkins, Robert B, Dubbink, Hendrikus J, Kros, Johan M, Wesseling, Pieter, Cheung, Kin Jip, Golfinopoulos, Vassilis, Baumert, Brigitta G, Gorlia, Thierry, Noushmehr, Houtan, French, Pim J

المساهمون: Tesileanu, C Mircea S, van den Bent, Martin J, Sanson, Marc, Wick, Wolfgang, Brandes, Alba A, Clement, Paul M, Erridge, Sara C, Vogelbaum, Michael A, Nowak, Anna K, Baurain, Jean F, Mason, Warren P, Wheeler, Helen, Chinot, Olivier L, Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter, Ruda', Roberta, Weller, Michael, McBain, Catherine, van Linde, Myra E, Sabedot, Thais S, Hoogstrate, Youri, von Deimling, Andrea, de Heer, Iri, van IJcken, Wilfred F J, Brouwer, Rutger W W, Aldape, Kenneth, Jenkins, Robert B, Dubbink, Hendrikus J, Kros, Johan M, Wesseling, Pieter, Cheung, Kin Jip, Golfinopoulos, Vassili, Baumert, Brigitta G, Gorlia, Thierry, Noushmehr, Houtan, French, Pim J

مصطلحات موضوعية: IDH mutant, 1p/19q non-codeleted, DNA methylation profiling, anaplastic glioma, patient prognostication

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33914057; info:eu-repo/semantics/altIdentifier/wos/WOS:000695839900017; volume:23; issue:9; firstpage:1547; lastpage:1559; numberofpages:13; journal:NEURO-ONCOLOGY; https://hdl.handle.net/2318/1888064Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85111541007

الإتاحة: https://doi.org/10.1093/neuonc/noab088Test
https://hdl.handle.net/2318/1888064Test

المؤلفون: Ruda R., Pellerino A., Pace A., Carapella C. M., Dealis C., Caroli M., Faedi M., Bello L., Migliore E., Marchese G., Bertero L., Cassoni P., Soffietti R.

المساهمون: Ruda R., Pellerino A., Pace A., Carapella C.M., Dealis C., Caroli M., Faedi M., Bello L., Migliore E., Marchese G., Bertero L., Cassoni P., Soffietti R.

مصطلحات موضوعية: Grade II glioma, Oligodendrogliomas IDH-mutant and 1p/19q codeleted, Response, Survival, Temozolomide, WHO 2016

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31556015; info:eu-repo/semantics/altIdentifier/wos/WOS:000494470200001; volume:145; issue:1; firstpage:115; lastpage:123; numberofpages:9; journal:JOURNAL OF NEURO-ONCOLOGY; http://hdl.handle.net/2318/1725344Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85072943280

الإتاحة: https://doi.org/10.1007/s11060-019-03277-xTest
http://hdl.handle.net/2318/1725344Test

المؤلفون: Appay, Romain, Dehais, Caroline, Maurage, Claude-Alain, Alentorn, Agusti, Carpentier, Catherine, Colin, Carole, Ducray, François, Escande, Fabienne, Idbaih, Ahmed, Kamoun, Aurélie, Marie, Yannick, Mokhtari, Karima, Tabouret, Emeline, Trabelsi, Nesrine, Uro-Coste, Emmanuelle, Delattre, Jean-Yves, Figarella-Branger, Dominique

المساهمون: Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service d'Anatomo-Cyto-Pathologie et de NeuroPathologie Hôpital de la Timone - APHM (ACPNP), Aix Marseille Université (AMU)-Hôpital de la Timone CHU - APHM (TIMONE), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hôpital neurologique et neurochirurgical Pierre Wertheimer CHU - HCL, Hospices Civils de Lyon (HCL), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), (le programme) Cartes d'identité des tumeurs (CIT), Ligue Nationales Contre le Cancer (LNCC), Hôpital de la Timone CHU - APHM (TIMONE), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), POLA Network: C Desenclos, H Sevestre, P Menei, A Rousseau, T Cruel, S Lopez, M-I Mihai, A Petit, C Adam, F Parker, P Dam-Hieu, I Quintin-Roué, S Eimer, H Loiseau, L Bekaert, F Chapon, D Ricard, C Godfraind, T Khallil, D Cazals-Hatem, T Faillot, C Gaultier, M C Tortel, I Carpiuc, P Richard, W Lahiani, H Aubriot-Lorton, F Ghiringhelli, C A Maurage, C Ramirez, E M Gueye, F Labrousse, O Chinot, L Bauchet, V Rigau, P Beauchesne, G Gauchotte, M Campone, D Loussouarn, D Fontaine, F Vandenbos-Burel, A Le Floch, P Roger, C Blechet, M Fesneau, A Carpentier, J Y Delattre, S Elouadhani-Hamdi, M Polivka, D Larrieu-Ciron, S Milin, P Colin, M D Diebold, D Chiforeanu, E Vauleon, O Langlois, A Laquerriere, F Forest, M J Motso-Fotso, M Andraud, G Runavot, B Lhermitte, G Noel, S Gaillard, C Villa, N Desse, C Rousselot-Denis, I Zemmoura, E Cohen-Moyal, E Uro-Coste, F Dhermain

المصدر: ISSN: 1522-8517.

مصطلحات موضوعية: CDKN2A homozygous deletion, IDH-mutant, IDH-mutant and 1p/19q codeleted, anaplastic astrocytoma, anaplastic oligodendroglioma, glioblastoma, microvascular proliferation, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31832685; hal-02441014; https://hal.science/hal-02441014Test; https://hal.science/hal-02441014/documentTest; https://hal.science/hal-02441014/file/noz124.pdfTest; PUBMED: 31832685; PUBMEDCENTRAL: PMC7145561

الإتاحة: https://doi.org/10.1093/neuonc/noz124Test
https://hal.science/hal-02441014Test
https://hal.science/hal-02441014/documentTest
https://hal.science/hal-02441014/file/noz124.pdfTest

المؤلفون: Wilfred F. J. van IJcken, Marc Sanson, Thais S. Sabedot, C Mircea S Tesileanu, Roberta Rudà, Thierry Gorlia, Olivier Chinot, Iris de Heer, Leland Rogers, Kenneth Aldape, Alba A. Brandes, Walter Taal, Kin Jip Cheung, Anna K. Nowak, Robert B. Jenkins, Michael A. Vogelbaum, Vassilis Golfinopoulos, Pim J. French, Wolfgang Wick, Myra van Linde, Hendrikus J. Dubbink, Johan M. Kros, M. Weller, Matthew E. Griffin, Rutger W W Brouwer, Brigitta G. Baumert, Sanjeev Gill, Houtan Noushmehr, Paul Clement, Catherine McBain, Helen Wheeler, Jean Francois Baurain, Pieter Wesseling, Sara Erridge, Youri Hoogstrate, Warren P. Mason, Andreas von Deimling, Martin J. van den Bent

المساهمون: Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service d’Oncologie Médicale [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Neurology, Cell biology, Pathology, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie

المصدر: Neuro-Oncology
Neuro-Oncology, Oxford University Press (OUP), 2021, 23 (9), pp.1547-1559. ⟨10.1093/neuonc/noab088⟩
Neuro-Oncology, 23(9), 1547-1559. Oxford University Press
Neuro-oncology, Vol. xx, no.xx, p. xx (2021)
Neuro-Oncology, 2021, 23 (9), pp.1547-1559. ⟨10.1093/neuonc/noab088⟩
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Neuro-oncology, 23(9), 1547-1559. Oxford University Press

مصطلحات موضوعية: Oncology, Cancer Research, ASTROCYTOMAS, [SDV]Life Sciences [q-bio], ESTUDOS PROSPECTIVOS, 1p/19q non-codeleted, 0302 clinical medicine, CDKN2A, Clinical endpoint, anaplastic glioma, Prospective Studies, Sequence Deletion, 0303 health sciences, Brain Neoplasms, Homozygote, Glioma, Prognosis, Isocitrate Dehydrogenase, 3. Good health, patient prognostication, GRADE, Chromosomes, Human, Pair 1, DNA methylation, SURVIVAL, DNA methylation profiling, IDH1, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, DNA Copy Number Variations, Clinical Neurology, Clinical Investigations, IDH mutant, CLASSIFICATION, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, medicine, AcademicSubjects/MED00300, Humans, 030304 developmental biology, Temozolomide, Science & Technology, Proportional hazards model, business.industry, CENTRAL-NERVOUS-SYSTEM, DNA Methylation, medicine.disease, Mutation, AcademicSubjects/MED00310, Neurology (clinical), Neurosciences & Neurology, business, 030217 neurology & neurosurgery, Anaplastic astrocytoma

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e028f0c3a1383a4e27bee5fc95e42bTest
http://europepmc.org/articles/PMC8408862Test

المؤلفون: Alessia Pellerino, Carmine M. Carapella, Lorenzo Bello, Roberta Rudà, Cristina Dealis, Riccardo Soffietti, Andrea Pace, Marina Faedi, Manuela Caroli, Luca Bertero, Giulia Marchese, Paola Cassoni, Enrica Migliore

المصدر: Journal of Neuro-Oncology. 145:115-123

مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Survival, Neuro oncology, MEDLINE, Grade II gliomas, Oligodendrogliomas IDH-mutant and 1p/19q codeleted, Response, Temozolomide, WHO 2016, World Health Organization, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Post-hoc analysis, medicine, Humans, Association (psychology), Antineoplastic Agents, Alkylating, Aged, Brain Neoplasms, business.industry, Glioma, Middle Aged, Survival Rate, Neurology, 030220 oncology & carcinogenesis, Female, Neurology (clinical), Neoplasm Grading, business, 030217 neurology & neurosurgery, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9bcde18f5945466953aff45fbf17c5aTest
https://doi.org/10.1007/s11060-019-03277-xTest

المؤلفون: David Schiff, Kurt A. Jaeckle, Evanthia Galanis, Kenneth Aldape, Donald Nordstrom, Stuart A. Grossman, Jeffrey S. Wefel, J. Gregory Cairncross, Michael A. Vogelbaum, Karla V. Ballman, F. Dhermain, Michael Weller, Martin Klein, Patrick J. Flynn, Wolfgang Wick, Paul D. Brown, S. Keith Anderson, Robert B. Jenkins, Caterina Giannini, Jesse G. Dixon, Jeffrey Raizer, Martin J. van den Bent, Jane H. Cerhan

المساهمون: Medical psychology, CCA - Cancer Treatment and quality of life, Neurology, Jaeckle K.A., Ballman K.V., Van Den Bent M., Giannini C., Galanis E., Brown P.D., Jenkins R.B., Cairncross J.G., Wick W., Weller M., Aldape K.D., Dixon J.G., Anderson S.K., Cerhan J.H., Wefel J.S., Klein M., Grossman S.A., Schiff D., Raizer J.J., Dhermain F., Nordstrom D.G., Flynn P.J., Vogelbaum M.A.

المصدر: Neuro-Oncology, 23(3), 457-467. Oxford University Press
Neuro Oncol
Jaeckle, K A, Ballman, K V, van den Bent, M, Giannini, C, Galanis, E, Brown, P D, Jenkins, R B, Cairncross, J G, Wick, W, Weller, M, Aldape, K D, Dixon, J G, Anderson, S K, Cerhan, J H, Wefel, J S, Klein, M, Grossman, S A, Schiff, D, Raizer, J J, Dhermain, F, Nordstrom, D G, Flynn, P J & Vogelbaum, M A 2021, ' CODEL : phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design ', Neuro-Oncology, vol. 23, no. 3, pp. 457-467 . https://doi.org/10.1093/neuonc/noaa168Test

مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, N0577, Oligodendroglioma, Clinical Investigations, Brain Neoplasm, SDG 3 - Good Health and Well-being, Internal medicine, CODEL, Clinical endpoint, 1p/19q, Temozolomide, Medicine, Humans, Adverse effect, business.industry, Proportional hazards model, Brain Neoplasms, Hazard ratio, medicine.disease, Isocitrate Dehydrogenase, Progression-Free Survival, Radiation therapy, Dacarbazine, codeleted, Concomitant, Neurology (clinical), business, medicine.drug, Human

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e03eddb3cba1b719188e63344f8cb2Test
https://research.vumc.nl/en/publications/33bff83f-2fc1-46f7-ae8d-4b1d356f3369Test

المؤلفون: Jaeckle K. A., Ballman K. V., Van Den Bent M., Giannini C., Galanis E., Brown P. D., Jenkins R. B., Cairncross J. G., Wick W., Weller M., Aldape K. D., Dixon J. G., Anderson S. K., Cerhan J. H., Wefel J. S., Klein M., Grossman S. A., Schiff D., Raizer J. J., Dhermain F., Nordstrom D. G., Flynn P. J., Vogelbaum M. A.

المساهمون: Jaeckle K.A., Ballman K.V., Van Den Bent M., Giannini C., Galanis E., Brown P.D., Jenkins R.B., Cairncross J.G., Wick W., Weller M., Aldape K.D., Dixon J.G., Anderson S.K., Cerhan J.H., Wefel J.S., Klein M., Grossman S.A., Schiff D., Raizer J.J., Dhermain F., Nordstrom D.G., Flynn P.J., Vogelbaum M.A.

مصطلحات موضوعية: 1p/19q, CODEL, codeleted, N0577, oligodendroglioma, Adult, Human, Isocitrate Dehydrogenase, Progression-Free Survival, Temozolomide, Brain Neoplasm

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32678879; info:eu-repo/semantics/altIdentifier/wos/WOS:000649004500014; volume:23; issue:3; firstpage:457; lastpage:467; numberofpages:11; journal:NEURO-ONCOLOGY; http://hdl.handle.net/11585/862496Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103606145

الإتاحة: https://doi.org/10.1093/neuonc/noaa168Test
http://hdl.handle.net/11585/862496Test

المؤلفون: Ruiz, Vanessa Y., Praska, Corinne E., Armstrong, Georgina, Kollmeyer, Thomas M., Yamada, Seiji, Decker, Paul A., Kosel, Matthew L., Eckel-Passow, Jeanette E., Lachance, Daniel H., Bainbridge, Matthew N., Melin, Beatrice S., Bondy, Melissa L., Jenkins, Robert B.

المصدر: Neuro-Oncology. 20(6):810-817

مصطلحات موضوعية: familial glioma (FG), IDH-mutant and 1p/19q-codeleted, IDH-mutant non-codeleted, IDH-wild type, lecular inversion probe (MIP)

وصف الملف: print

الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-148725Test

المؤلفون: Mcnamara, Mairead, Jiang, Haiyan, Fat, Mary Jane Lim, Sahebjam, Solmaz, Kiehl, Tim Rasmus, Karamchandani, Jason, Coire, Claire, Chung, Caroline, Millar, Barbara-Ann, Laperriere, Normand, Mason, Warren P

المصدر: Mcnamara , M , Jiang , H , Fat , M J L , Sahebjam , S , Kiehl , T R , Karamchandani , J , Coire , C , Chung , C , Millar , B-A , Laperriere , N & Mason , W P 2014 , ' Temozolomide for 1p19q co-deleted and partially deleted gliomas ' , European Society of Medical Oncology , Madrid , 26/09/14 - 30/09/14 .

مصطلحات موضوعية: 1p19q codeleted glioma, Temozolomide, PCV, Radiotherapy

الإتاحة: https://research.manchester.ac.uk/en/publications/9b1676f5-866b-4c6a-85f3-1422c168ee69Test

المؤلفون: Mcnamara, Mairead

المساهمون: NA, NA NA

المصدر: Mcnamara , M & NA , NA NA (ed.) 2014 , ' Delaying radiotherapy in 1p19q co-deleted and partially deleted gliomas ' , 19th Annual Scientific Meeting of Society for Neuro-Oncology , Miami, Florida , 13/11/14 - 16/11/14 pp. NA-NA .

مصطلحات موضوعية: 1p19q codeleted glioma, PCV, Radiotherapy

الإتاحة: https://research.manchester.ac.uk/en/publications/0a099919-d67a-405a-be8e-629805837efcTest